NCT00003869View on ClinicalTrials.gov

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
DRUG

carboxyamidotriazole

Given PO

OTHER

placebo

Given PO

PROCEDURE

quality-of-life assessment

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

North Central Cancer Treatment Group, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH